543. Molnupiravir Maintains Antiviral Activity Against SARS-CoV-2 Variants In Vitro and in Early Clinical StudiesJay A. Grobler, Julie Strizki, Nicholas Murgolo et al.|Open Forum Infectious Diseases|2021Cited by 10